Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis

Table 4 Documented suspected side effects of tacrolimus during intravenous and oral treatment

Suspected side effect	n = 22
None, n (%)	10/22 (45.5)
Treatment discontinuation due to side effects, n (%)	2/22 (9.1) (1 due to severe vomiting, 1 due to anemia and leukopenia)
Nausea ± vomiting, n (%)	3/22 (13.6)
Stomach pain, n (%)	1/22 (4.5)
Headache, n (%)	1/22 (4.5)
Tremor, n (%)	4/22 (18.2)
Paresthesias, n (%)	1/22 (4.5)
Photosensitivity, n (%)	1/22 (4.5)
Itching rash, n (%)	1/22 (4.5)
Joint or back pain, n (%)	1/22 (4.5)
Muscle pain or cramps, n (%)	2/22 (9.1)
Temperature intolerance, n (%)	3/22 (13.6)
Anemia, leukopenia, n (%)	1/22 (4.5)
Loss of hair, n (%)	1/22 (4.5)